AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 13, 2026

Bioventus Inc. BVS Stock Forecast

AI-powered price prediction and analysis for Bioventus Inc. · Alpha · vs marketSwitch to Total

Follow
AI 90-Day Forecast HOLD Alpha
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See BVS's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

BVS
Fundamentals

Key Statistics

Market Cap$1.14B
P/E Ratio20.9x
P/B Ratio4.99x
EPS$0.69
ROE23.9%
Net Margin9.4%
Revenue$581M
Current Ratio1.69x
D/E Ratio1.73x
Company

About Bioventus Inc.

Bioventus Inc. (BVS) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.

Industrial Applications and Services Surgical & Medical Instruments & Apparatus Nasdaq Small Cap
News

Latest News

  • Loading...

Where BVS sits on the market map

Industrial Applications and Services · Surgical & Medical Instruments & Apparatus
Explore the map →
Industry Peers

Surgical & Medical Instruments & Apparatus Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
BVS Bioventus Inc. ▶ $1.14B 20.9x
SYK Stryker Corp ▼ $108.38B 29.1x
MMM 3m Co ▼ $83.94B 28.0x
BSX Boston Scientific Corp ▼ $62.77B 17.1x
BDX Becton Dickinson & Co ▼ $51.04B 54.2x
MDLN Medline Inc. ▶ $46.94B –
RMD Resmed Inc ▼ $33.91B 22.3x
DXCM Dexcom Inc ▶ $32.42B 32.4x
WST West Pharmaceutical Services Inc ▼ $26.17B 46.3x
SOLV Solventum Corp ▼ $14.69B 10.2x
BAX Baxter International Inc ▶ $12.87B –
PEN Penumbra Inc ▼ $12.61B 78.5x
GMED Globus Medical Inc ▼ $10.25B 19.1x
GKOS Glaukos Corp ▲ $9.76B –
PODD Insulet Corp ▼ $9.58B 25.5x
STVN Stevanato Group S.P.A. ▲ $5.83B –
HAE Haemonetics Corp ▼ $5.54B 57.5x
TFX Teleflex Inc ▼ $5.27B –
MMSI Merit Medical Systems Inc ▼ $5.26B 36.2x
MMED Minimed Group, Inc. ▶ $5.18B –
HTFL Heartflow, Inc. ▲ $4.38B –
ICUI Icu Medical Inc/De ▼ $4.08B –
IRTC Irhythm Holdings, Inc. ▼ $3.55B –
PLSE Pulse Biosciences, Inc. ▲ $3.46B –
ATRC Atricure, Inc. ▶ $2.89B –
UFPT Ufp Technologies Inc ▶ $2.28B 31.5x
INSP Inspire Medical Systems, Inc. ▶ $1.99B 14.7x
LMAT Lemaitre Vascular Inc ▲ $1.86B 28.4x
ATEC Alphatec Holdings, Inc. ▲ $1.67B –
NVCR Novocure Ltd ▲ $1.67B –
KMTS Kestra Medical Technologies, Ltd. ▲ $1.61B –
DRTS Alpha Tau Medical Ltd. ▲ $1.21B –
TNDM Tandem Diabetes Care Inc ▶ $1.16B –
IRMD Iradimed Corp ▲ $1.15B 49.7x
PRCT Procept Biorobotics Corp ▲ $1.09B –
IART Integra Lifesciences Holdings Corp ▼ $1.08B –
AORT Artivion, Inc. ▲ $1.04B –
SIBN Si-Bone, Inc. ▲ $882M –
SGP Spyglass Pharma, Inc. ▲ $800M –
BBNX Beta Bionics, Inc. ▲ $796M –
MDXG Mimedx Group, Inc. ▲ $684M –
KIDS Orthopediatrics Corp ▶ $573M –
SSII Ss Innovations International, Inc. ▲ $511M –
TCMD Tactile Systems Technology Inc ▲ $505M 20.3x
BWAY Brainsway Ltd. ▲ $467M –
SGHT Sight Sciences, Inc. ▲ $462M –
CERS Cerus Corp ▲ $455M –
ANGO Angiodynamics Inc ▲ $451M –
NPCE Neuropace Inc ▶ $435M –
RCEL Avita Medical, Inc. ▲ $413M –
CARL Carlsmed, Inc. ▲ $395M –
OFIX Orthofix Medical Inc. ▼ $377M –
EMBC Embecta Corp. ▲ $351M 4.0x
OBIO Orchestra Biomed Holdings, Inc. ▲ $344M –
CLPT Clearpoint Neuro, Inc. ▲ $299M –
MOBI Mobia Medical, Inc. ▲ $283M –
ANIK Anika Therapeutics, Inc. ▲ $275M –
TMCI Treace Medical Concepts, Inc. ▲ $267M –
OSUR Orasure Technologies Inc ▲ $263M –
PROF Profound Medical Corp. ▲ $256M –
FAQ

FAQ

Is Bioventus Inc. a good stock to buy?

Our AI analyzes Bioventus Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Bioventus Inc. predictions?

A per-ticker accuracy statistic for BVS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Bioventus Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Bioventus Inc.? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.